CASC
Cascadian Therapeutics, Inc.
CASC
CASC
Delisted
CASC was delisted on the 8th of March, 2018.
91 hedge funds and large institutions have $152M invested in Cascadian Therapeutics, Inc. in 2017 Q4 according to their latest regulatory filings, with 18 funds opening new positions, 30 increasing their positions, 19 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
9% less capital invested
Capital invested by funds: $166M → $152M (-$14.1M)
Holders
91
Holding in Top 10
1
Calls
$50K
Puts
$1K
Top Buyers
| 1 | +$2.67M | |
| 2 | +$2.46M | |
| 3 | +$2.4M | |
| 4 |
Goldman Sachs
New York
|
+$2.28M |
| 5 |
KCM
Kennedy Capital Management
St Louis,
Missouri
|
+$1.83M |
Top Sellers
| 1 | -$12.3M | |
| 2 | -$4.89M | |
| 3 | -$902K | |
| 4 |
SKK
Shepherd Kaplan Krochuk
Boston,
Massachusetts
|
-$154K |
| 5 |
PAWC
P.A.W. Capital
Greenwich,
Connecticut
|
-$148K |